N-(4-(4-ethylpiperazin-1-yl)phenyl)benzo[g]quinolin-4-amine

ID: ALA494487

Chembl Id: CHEMBL494487

Cas Number: 115618-99-0

PubChem CID: 159481

Max Phase: Preclinical

Molecular Formula: C25H26N4

Molecular Weight: 382.51

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN1CCN(c2ccc(Nc3ccnc4cc5ccccc5cc34)cc2)CC1

Standard InChI:  InChI=1S/C25H26N4/c1-2-28-13-15-29(16-14-28)22-9-7-21(8-10-22)27-24-11-12-26-25-18-20-6-4-3-5-19(20)17-23(24)25/h3-12,17-18H,2,13-16H2,1H3,(H,26,27)

Standard InChI Key:  FGVVQTVRBTWGJA-UHFFFAOYSA-N

Associated Targets(non-human)

Vaccinia virus (4609 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPG071 DNA polymerase (35 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 382.51Molecular Weight (Monoisotopic): 382.2157AlogP: 5.27#Rotatable Bonds: 4
Polar Surface Area: 31.40Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.29CX LogP: 4.87CX LogD: 3.79
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.49Np Likeness Score: -1.37

References

1. Ciustea M, Silverman JE, Druck Shudofsky AM, Ricciardi RP..  (2008)  Identification of non-nucleoside DNA synthesis inhibitors of vaccinia virus by high-throughput screening.,  51  (20): [PMID:18808105] [10.1021/jm800366g]
2. Silber BM, Gever JR, Li Z, Gallardo-Godoy A, Renslo AR, Widjaja K, Irwin JJ, Rao S, Jacobson MP, Ghaemmaghami S, Prusiner SB..  (2013)  Antiprion compounds that reduce PrP(Sc) levels in dividing and stationary-phase cells.,  21  (24): [PMID:24183589] [10.1016/j.bmc.2013.09.022]
3.  (2015)  Therapeutic compounds for blocking DNA synthesis of POX viruses,